Last reviewed · How we verify

NCT06909227: PLANN

Relevance of Veinous Lactates to Predict Postoperative Complications in Children 0-1 Years

Recruiting now Last updated 1 May 2025
What this trial tests

trial testing surgery under general anesthesia in General Anesthesia in 500 participants. Currently enrolling.

Timeline
27 March 2025
Primary endpoint
30 September 2026
30 September 2026

Quick facts

Lead sponsorHôpital Armand Trousseau
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment500
Start date27 March 2025
Primary completion30 September 2026
Estimated completion30 September 2026
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

Hôpital Armand Trousseau

Who can join

Adults 0 to 1, any sex, with General Anesthesia or Infant. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will investigate if the dosage of veinous lactate at the end of a surgical procedure is related to post-operative complications occurring within 3 months in young infants aged 0-1 years. Blood samples are acquired routinely before emergence of general anesthesia, from the IV line put in place for anesthesia. The investigators hypothesized that elevated lactates would be associated with more postoperative complications in this population, as is the case in adults.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for General Anesthesia

Currently open trials in the same condition.

Other Hôpital Armand Trousseau trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06909227.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing